Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer
Technology appraisal guidance
Reference number: TA563
Published:
Evidence
Review and download supporting evidence. Includes the full guideline if available.